Trial Information

Summary: Are you interested in taking part in a study to reduce your breast cancer risk? Tamoxifen/MRI Breast Cancer Prevention Study

We are currently conducting a study of enhanced MRI breast cancer screening and tamoxifen breast cancer prevention.

Eligible women are between the ages of 25-45, and have family members with breast or ovarian cancer or have had a breast biopsy.

We are currently enrolling high-risk women at sites in Philadelphia, PA; Boston, MA; Detroit, MI; Chicago, IL; Los Angeles, CA; Rochester, MN; Jacksonville, FL; and Milan, Italy and are inviting you to participate.

Study participants receive a mammogram and MRI every 6 months for the 2-year study period and will take either tamoxifen or placebo (sugar pill) for one year (no medication during the second year). Participating women who are eligible will also receive free tamoxifen through the end of 2006.

All procedures and study medications will be paid for by the study. Participants will also be compensated for their time.

If you would like to discuss the study or if you have any questions, please call toll free at (888) 666-6002. Please forward this announcement to anyone else who may be interested. Thank you!

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:55 AM